144 related articles for article (PubMed ID: 37234775)
1. Clinical characteristics and outcomes of children with Kawasaki disease combined with sepsis in the pediatric intensive care unit.
Yang Y; Huang J; Yan H; Li X; Liu P; Zhou W; Zhang X; Lu X; Xiao Z
Front Cell Infect Microbiol; 2023; 13():1101428. PubMed ID: 37234775
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital.
Kuo CC; Lee YS; Lin MR; Hsia SH; Chen CJ; Chiu CH; Hwang MS; Huang YC
J Microbiol Immunol Infect; 2018 Apr; 51(2):184-190. PubMed ID: 27591913
[TBL] [Abstract][Full Text] [Related]
3. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
[TBL] [Abstract][Full Text] [Related]
4. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
Niu MM; Jiang Q; Ruan JW; Liu HH; Chen WX; Qiu Z; Fan GZ; Li RX; Wei W; Hu P
Clin Exp Med; 2021 Nov; 21(4):633-643. PubMed ID: 33839960
[TBL] [Abstract][Full Text] [Related]
7. Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.
Lin YJ; Lin IC; Yu HR; Kuo HC; Yang KD; Chang WC; Liang CD; Liu SF; Kuo HC
Pediatr Cardiol; 2013 Feb; 34(2):250-5. PubMed ID: 22810044
[TBL] [Abstract][Full Text] [Related]
8. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
11. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
12. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
13. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
14. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
[TBL] [Abstract][Full Text] [Related]
15. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
[TBL] [Abstract][Full Text] [Related]
16. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of recurrent Kawasaki disease in 20 children].
Zou LX; Gong FQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):617-9. PubMed ID: 18947484
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
[No Abstract] [Full Text] [Related]
19. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
[TBL] [Abstract][Full Text] [Related]
20. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
Han CL; Zhao SL
Med Sci Monit; 2018 Oct; 24():7264-7270. PubMed ID: 30307902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
